MedTrace Logo

Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.

NCT00301327 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-05-30

No results posted yet for this study

Summary

This is a multi-center, randomized, double blind, vehicle controlled, study designed to evaluate the pediculicidal activity of Summers 5% L.A. compared to a vehicle control.

Conditions

  • Head Lice

Interventions

DRUG

Summers 5% L.A.

Sponsors & Collaborators

  • Summers Laboratories

    lead INDUSTRY

Principal Investigators

  • Terri Meinking · Global Health Associates of Miami

  • Anne Lucky, Dr. · Dermatology Research Associates

  • Jon Thomas, Dr. · Alegent Health

  • E.A. Clark, Dr. · Diagnostic Clinic of Longview, TX

  • Peter E Silas, Dr. · Advanced Clinical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301327 on ClinicalTrials.gov